- Home
- AIEV vs OMIC Comparison
AIEV vs OMIC Comparison
Compare AIEV & OMIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AIEV
- OMIC
- Stock Information
- Founded
- AIEV 2011
- OMIC 2016
- Country
- AIEV United States
- OMIC United States
- Employees
- AIEV N/A
- OMIC N/A
- Industry
- AIEV Blank Checks
- OMIC Medical/Dental Instruments
- Sector
- AIEV Finance
- OMIC Health Care
- Exchange
- AIEV Nasdaq
- OMIC Nasdaq
- Market Cap
- AIEV 42.6M
- OMIC 36.8M
- IPO Year
- AIEV N/A
- OMIC 2021
- Fundamental
- Price
- AIEV $0.46
- OMIC $15.26
- Analyst Decision
- AIEV
- OMIC Hold
- Analyst Count
- AIEV 0
- OMIC 2
- Target Price
- AIEV N/A
- OMIC $10.75
- AVG Volume (30 Days)
- AIEV 48.5K
- OMIC 42.0K
- Earning Date
- AIEV 11-15-2024
- OMIC 11-12-2024
- Dividend Yield
- AIEV N/A
- OMIC N/A
- EPS Growth
- AIEV N/A
- OMIC N/A
- EPS
- AIEV N/A
- OMIC N/A
- Revenue
- AIEV N/A
- OMIC $2,723,000.00
- Revenue This Year
- AIEV N/A
- OMIC $10.44
- Revenue Next Year
- AIEV N/A
- OMIC $221.93
- P/E Ratio
- AIEV N/A
- OMIC N/A
- Revenue Growth
- AIEV N/A
- OMIC 27.66
- 52 Week Low
- AIEV $0.40
- OMIC $5.34
- 52 Week High
- AIEV $12.12
- OMIC $19.80
- Technical
- Relative Strength Index (RSI)
- AIEV N/A
- OMIC 61.04
- Support Level
- AIEV N/A
- OMIC $13.71
- Resistance Level
- AIEV N/A
- OMIC $15.75
- Average True Range (ATR)
- AIEV 0.00
- OMIC 1.07
- MACD
- AIEV 0.00
- OMIC -0.28
- Stochastic Oscillator
- AIEV 0.00
- OMIC 59.29
About AIEV Thunder Power Holdings Inc. Common Stock
Thunder Power Holdings Inc is engaged in the design and development of high-performance electric vehicles.
About OMIC Singular Genomics Systems Inc.
Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built to address different applications. The G4 Sequencing Platform is designed to target the NGS market. The PX Integrated Solution is designed to target the single cell, spatial analysis and proteomics markets. Both integrated solutions are used in many different and diverse market segments, including basic biology, oncology, immunology, neurology, genetic diseases, infectious diseases, the human microbiome and many others.